Patient stories

      Test
      Focus Area
      Format
      Evidence
FILTER BY TESTS
DecisionDx-Melanoma DecisionDx-SCC MyPath Melanoma TissueCypher DecisionDx-UM IDgenetix

Facing Melanoma: Leah B's Journey from PA to Patient

Leah never imagined she’d go from treating patients to becoming one. Just five days after her wedding, she received a life-changing call—she had melanoma. With countless questions about her future, she turned to DecisionDx-Melanoma for answers. Her test results provided clarity, helping her avoid unnecessary surgeries and find peace of mind. Watch her inspiring journey of resilience, hope, and the power of knowing.

Cutaneous Melanoma DecisionDx-Melanoma
Read More

It's melanoma, now what?

Melanoma is one of the most common cancers found among adults, aged 15-29, in the U.S. and the deadliest if not caught early. There are emerging technologies to help identify a patient’s risk for recurrence and metastasis such as gene expression profiling. Learn about DecisionDX-Melanoma, which is a predictive test to help patients make the most informed treatment decisions.

Cutaneous Melanoma DecisionDx-Melanoma
Read More

From Fear to Confidence: DecisionDx-Melanoma. Greg’s Story of Empowerment Over a Melanoma Diagnosis

Discover Greg’s inspiring journey from a cancer diagnosis to a life of outdoor adventures, empowered by the DecisionDx-Melanoma test. Follow his path to knowledge and resilience in the face of melanoma.

Cutaneous Melanoma DecisionDx-Melanoma
View More Link icon

Don't let fear define your journey: a uveal melanoma patient journey

Danet didn’t let fear of the unknown define her uveal melanoma journey. Hear how Castle Biosciences DecisionDx-UM test impacted her treatment.

Uveal Melanoma DecisionDx-UM
View More Link icon
Click to play "Be Your Own Advocate: Morgan England, Stage III Melanoma Survivor, Shares Her Story" video

Be your own advocate: Morgan England, Stage III melanoma survivor, shares her story

As a Stage III Melanoma survivor, Morgan speaks on how important it is to be your own advocate. After her diagnosis, she requested the DecisionDx-Melanoma test from her doctor for the additional information it can provide. The results she received from her DecisionDx-Melanoma test report continue to help reduce her anxiety and provide confidence about her future.

Cutaneous Melanoma DecisionDx-Melanoma
Read More
Click to play "A Life Changing Prognosis of Uveal Melanoma: Kevin's Story" video

A life-changing prognosis of uveal melanoma: Kevin’s story

After being diagnosed with uveal (or ocular) melanoma, Kevin was directed to explore the benefits and indications of Castle Biosciences' DecisionDx-UM gene expression profile (GEP) test, which predicts a patient’s risk based upon their tumor’s own unique biology. The findings of the test, Kevin says, "were of huge importance to myself and my family. They put me at rest and we could all move on. The Castle's uveal melanoma prognostic platform can truly be life-changing."

DecisionDx-UM
View More Link icon